The University of Padua is an Italian university located in the city of Padua, region of Veneto, northern Italy. The University of Padua was founded in 1222 by a group of students and teachers from Bologna. Padua is the second-oldest university in Italy and the world's fifth-oldest surviving university.

During the past decade, Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" #1 collaborator was "Conegliano Veneto's Hospital, Conegliano Veneto, Italy" with 1 trials as a collaborator, "Mirano's Hospital, Mirano, Italy" with 1 trials as a collaborator and "San Giacomo Apostolo Hospital, Castelfranco Veneto, Italy" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" are "Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (2 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (1 trials) and "Myocardial Reperfusion Injury" (1 trials). Many other conditions were trialed in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" in a lesser frequency.

Most popular intervention types in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" are "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "Postconditioning" (1 trials), "Primary angioplasty and stenting without additional intervention" (1 trials) and "Tryton" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".